Home
>
National Drug Code (NDC)
>
Banzel
Banzel - 62856-584-46 - (rufinamide)
Drug Information of Banzel
| Product NDC: | 62856-584 |
| Proprietary Name: | Banzel |
| Non Proprietary Name: | rufinamide |
| Active Ingredient(s): | 40 mg/mL & nbsp; rufinamide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Banzel
| Product NDC: | 62856-584 |
| Labeler Name: | Eisai Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA201367 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110303 |
Package Information of Banzel
| Package NDC: | 62856-584-46 |
| Package Description: | 1 BOTTLE in 1 CARTON (62856-584-46) > 460 mL in 1 BOTTLE |
NDC Information of Banzel
| NDC Code | 62856-584-46 |
| Proprietary Name | Banzel |
| Package Description | 1 BOTTLE in 1 CARTON (62856-584-46) > 460 mL in 1 BOTTLE |
| Product NDC | 62856-584 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | rufinamide |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20110303 |
| Marketing Category Name | NDA |
| Labeler Name | Eisai Inc. |
| Substance Name | RUFINAMIDE |
| Strength Number | 40 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |
